findmyKOL
Clinical trialNCT03913715Active, not recruitingInterventional

Ostomy Rural Telehealth Training Cancer Survivors

SponsorAbramson Cancer Center at Penn MedicineEnrollment204OstomyQuality of LifeTelehealth
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Over one million individuals in the U.S. have ostomies. The American Cancer Society estimates 43,030 rectal cancer cases and 81,190 bladder cancer cases will be diagnosed in 2018.Of these, at least 30,000 will receive ostomies, and an additional unknown number due to gynecologic, other gastrointestinal, or other gastro-urinary tumors. The health-related quality of life impact is tremendous and greater than with many other cancer treatments. An ostomy is often a prolonged or lifelong disabling problem for cancer survivors. The adaptation period is quite variable. In our R01 study, 18% of participants took at least one year to be comfortable, or never felt comfortable, in managing their ostomy care. Importantly, many patients cannot attend in-person self-management programs or patient groups for a myriad of reasons, including distance to travel, lack of access to transportation, monetary outlays, competing demands (such as work), or comorbidities making travel difficult. In addition, a national shortage of OCNs means patients with an ostomy, whether newly placed or a long-term issue, receive little help. It is imperative to study interventions for rural survivors aimed to limit family financial burdens, improve ostomy outcomes, and improve survivors' well-being.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas, United States

  • City of Hope

    Duarte, California, United States

  • Loma Linda University Health

    Loma Linda, California, United States

  • University of New Mexico

    Albuquerque, New Mexico, United States

  • University of North Carolina

    Chapel Hill, North Carolina, United States

  • Sanford Research Center

    Fargo, North Dakota, United States

  • Geisinger

    Danville, Pennsylvania, United States

  • Lancaster General Hospital

    Lancaster, Pennsylvania, United States

  • Penn Medicine

    Philadelphia, Pennsylvania, United States

  • University of South Carolina Greenville (prisma Health)

    Greenville, South Carolina, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Aug 2019
Primary completion
1 Sept 2025
Completion
31 Oct 2026
Last update posted
11 Jul 2025
Registered enrollment
204
Registry id
NCT03913715

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.